For the Quarter Ending September 2025
APAC
• In China, the Cyclopentanone Price Index fell by 14.69% quarter-over-quarter, in Q3 2025, reflecting oversupplied market conditions.
• The average Cyclopentanone price for the quarter was approximately USD 3203.33/MT, signaling softening from prior periods.
• Cyclopentanone Spot Price movements reflect oversupply dynamics, while producers monitor feedstock costs and margin pressure amid weak demand.
• Price Index performance suggests limited upside risks as Demand Outlook remains mixed across APAC leading industries and consumer end-markets.
• Production Cost Trend remained stable, supported by abundant supply and steady energy inputs, constraining price recovery amid volatility.
• Inventory levels stayed comfortable, enabling competitive pricing and reinforcing the current Price Index softness in the quarter.
• Demand Outlook remains cautious as downstream sectors such as fragrance and pharmaceuticals balance inventory cycles.
• Export demand developments and Asian destocking patterns influenced Cyclopentanone Price Index trajectories through September 2025.
Why did the price of Cyclopentanone change in September 2025 in APAC?
• Oversupply relative to demand in APAC pressured Cyclopentanone prices amid highly competitive markets during September 2025.
• Cost pressures from steady feedstock costs limited price upside in APAC despite some export activity.
• Logistics and inventory dynamics, destocking tendencies across Asia, contributed to overall price stabilization in September 2025.
North America
• The Cyclopentanone Price Index in North America demonstrated fluctuations throughout Q3 2025, driven by inconsistent demand from the downstream pharmaceutical and fragrance sectors.
• During July and August 2025, the Cyclopentanone Spot Price saw moderate increases, influenced by constrained regional supplies amid scheduled plant maintenance and rising feedstock costs.
• In September 2025, prices declined marginally, as supply conditions stabilized and downstream manufacturers reduced procurement activities following inventory accumulation in earlier months.
• The Cyclopentanone Production Cost Trend remained moderately high during the quarter due to elevated energy costs and raw material volatility.
• The Cyclopentanone Demand Outlook for North America was mixed, as demand from the pharmaceutical industry remained steady, while orders from the agrochemical sector weakened due to seasonal slowdowns.
• The Cyclopentanone Price Forecast for the next quarter indicates potential price stabilization, contingent on energy market trends and steady demand from high-value chemical segments.
Europe
• The European Cyclopentanone Price Index also depicted fluctuations during Q3 2025, mainly influenced by varying feedstock prices and subdued performance of end-use industries.
• Early in the quarter, Cyclopentanone Spot Prices rose slightly due to limited product availability in key manufacturing hubs and firm energy costs across the region.
• However, in September 2025, prices declined owing to improved supply chains, reduced buying sentiment, and weakening demand from the fragrance and polymer sectors.
• The Cyclopentanone Production Cost Trend eased toward the end of Q3 as energy inputs and feedstock costs softened, leading to reduced production margins for manufacturers.
• The Cyclopentanone Demand Outlook in Europe remains cautious, with market participants closely monitoring energy prices and downstream consumption patterns, particularly from the pharmaceutical sector.
• The Cyclopentanone Price Forecast suggests moderate recovery potential in early Q4, contingent on raw material costs and seasonal improvement in demand from the fragrance industry.
For the Quarter Ending June 2025
APAC
• The Cyclopentanone Price Index in China witnessed a consistent downward trend over Q2 2025, primarily driven by oversupply conditions and weakening demand sentiment. The market faced a notable imbalance between production and consumption, despite relatively strong performance from end-user sectors such as automotive and industrial manufacturing.
• The Cyclopentanone Spot Price, settling at USD 3573/MT during June 2025, was pressured by persistent inventory buildup due to steady production and high plant operating rates. There were no significant raw material shortages, and feedstock Adipic Acid availability remained healthy, contributing to a declining Cyclopentanone Production Cost Trend.
• Export volumes declined amid reduced global inquiries, particularly affecting Chinese manufacturers. With rising competition among domestic producers and a surge in stockpiles, sellers were compelled to reduce prices, intensifying the downward pressure on the Price Index.
• In July 2025, the Cyclopentanone Price Index continued to decline due to aggressive price competition, abundant inventories, and lackluster demand from construction and electronic chemical intermediates. Although sectors like automotive and high-tech manufacturing showed resilience—e.g., China-made vehicle sales increased YoY and NEV production remained strong—this demand was insufficient to balance out the market oversupply.
• The Cyclopentanone Demand Outlook remains cautiously optimistic for Q3 2025, contingent upon export recovery and policy-driven infrastructure spending. However, in the near term, the Cyclopentanone Price Forecast suggests a bearish tone unless significant consumption uptick or supply rationalization occurs.
Europe
• During Q2 2025, the Cyclopentanone Price Index in Germany fluctuated amidst a mixed industrial landscape. Despite stable availability of feedstocks and moderate production levels, downstream market sentiment remained fragile due to regional economic uncertainty.
• The Cyclopentanone Demand Outlook remained under pressure as key consuming sectors such as insulation and coatings operated cautiously amid tepid construction and limited export orders. Inventories grew modestly, prompting periodic downward corrections in the Spot Price.
• In July 2025, the Price Index exhibited continued fluctuations, largely influenced by weak international demand, erratic restocking behavior, and subdued momentum in the construction and automotive segments. Despite no significant disruptions in the supply chain, producers lowered offers to remain competitive in a buyer-driven market.
• The Cyclopentanone Production Cost Trend remained manageable due to stable upstream input prices, yet low operating margins pressured manufacturers to curtail output in some regions. The Cyclopentanone Price Forecast for Europe remains volatile in the near term, dependent on fiscal stimulus and improvement in industrial consumption patterns.
North America
• The North American market experienced erratic shifts in the Cyclopentanone Price Index during Q2 2025, shaped by uneven demand recovery and a fragmented downstream industrial outlook. With domestic manufacturing under strain from economic headwinds, suppliers faced uncertain offtake volumes.
• The Cyclopentanone Spot Price saw periodic adjustments as participants responded to inconsistent restocking cycles, with export orders from Latin America providing some support. However, rising inventories and conservative purchasing limited the upside in prices.
• By July 2025, the Price Index had declined marginally, primarily due to lackluster demand from insulation, polymer additives, and fine chemical applications. Even with stable feedstock availability and no major production disruptions, suppliers were unable to maintain earlier pricing levels.
• The Cyclopentanone Production Cost Trend stayed steady, but the broader market was weighed down by inflation concerns, slower infrastructure development, and weak housing starts. Looking ahead, the Cyclopentanone Demand Outlook depends on energy sector recovery, building material consumption, and policy-driven industrial revitalization. The Price Forecast for Q3 reflects guarded expectations with a risk of further downside unless demand normalizes.
For the Quarter Ending March 2025
North America
In Q1 2025, the North American Cyclopentanone market experienced price fluctuations, influenced by sectoral demands and economic conditions. January saw a modest price increase due to steady demand from the pharmaceutical sector, driven by the synthesis of active pharmaceutical ingredients (APIs). However, February witnessed a slight dip as the rubber and agrochemical industries faced challenges, with companies experiencing market pressures. March brought renewed price pressures, driven by rising raw material costs and supply chain disruptions.
The pharmaceutical sector's performance notably impacted Cyclopentanone demand. The increasing need for high-purity Cyclopentanone in drug synthesis contributed to market growth. However, the rubber and agrochemical industries faced challenges, with production slowdowns impacting demand for Cyclopentanone derivatives used in manufacturing processes.
Overall, North America's Cyclopentanone market in Q1 2025 was shaped by a recovering pharmaceutical sector and struggling rubber and agrochemical industries, leading to a nuanced pricing landscape influenced by varying sectoral demands and economic factors.
Asia
In Q1 2025, the Asian Cyclopentanone market continued to experience downward price pressure, a trend persisting from the latter half of 2024. This decline was primarily attributed to an oversupply situation, with high inventories exceeding consumption levels. Despite a slight improvement in manufacturing activity and strong export growth, demand from key application sectors such as pharmaceuticals, flavors, and agrochemicals remained stable but weak. The lackluster performance of these sectors further dampened demand, leading to sustained price pressure throughout the quarter.
In China, the largest producer in the region, domestic demand softened slightly due to pharmaceutical inventory optimization. However, international buyers capitalized on lower prices, stocking up for Q1 2025. The fragrance industry's seasonal peak partially offset the domestic slowdown.
Overall, the Asian Cyclopentanone market in Q1 2025 was characterized by oversupply, leading to sustained price pressure. Positive macroeconomic indicators like export growth and improved manufacturing activity had limited impact on Cyclopentanone demand. Weak growth in key sectors and cautious procurement strategies created challenges for market participants, who struggled with high inventories and profit margins.
Europe
In Q1 2025, the European Cyclopentanone market experienced moderate price fluctuations, influenced by sectoral demands and economic conditions. January saw stable prices due to balanced supply and demand, even as economic factors slowed the construction and automotive sectors. High interest rates and reduced trade activity tempered demand, keeping commodity prices steady. Germany’s cautious market approach, combined with ample inventory levels, limited price fluctuations despite attempts to curb production and stabilize margins. However, competition from imports prevented any significant price increases, maintaining a steady market landscape.
The pharmaceutical sector's performance notably impacted Cyclopentanone demand. The increasing use of Cyclopentanone in drug synthesis contributed to market growth. However, the rubber and agrochemical industries faced challenges, with production slowdowns impacting demand for Cyclopentanone derivatives used in manufacturing processes.
Overall, Europe's Cyclopentanone market in Q1 2025 was shaped by stable demand in key sectors, balanced supply, and cautious economic sentiment, leading to a nuanced pricing landscape.
For the Quarter Ending December 2024
North America
In Q4 2024, the Cyclopentanone market in the North American region, particularly USA exhibited price stability. October saw stable prices, likely due to balanced supply and demand, despite sluggish demand and cautious inventory management reflecting in moderate offtakes. Rising feedstock costs, driven by higher natural gas prices, impacted production costs. November maintained price stability, mirroring the unchanged price. Reduced imports due to trade issues created upward pressure on Cyclopentanone, offset by subdued demand. A rising PMI and energy costs indicated potential upward pressure on production costs. Decreased container imports, a seasonal factor, also had a minor negative impact.
December's stable price indicated stability for Cyclopentanone, despite supply chain disruptions and moderate supply. Reduced export rates and subdued demand from the agrochemical sector due to cautious buying impacted Cyclopentanone. Lower feedstock ammonia cost support further challenged production costs.
Overall, Q4 2024 showed Cyclopentanone price stability in the US, influenced by balanced supply and demand. However, rising production costs due to energy and feedstock prices, coupled with subdued agricultural sector demand, created challenges for market participants. Macroeconomic conditions and seasonal factors were key influencers.
APAC
In Q4 2024 , the Cyclopentanone market in the APAC region, particularly China saw a price decline driven by oversupply and moderate demand. October started with a 4% price drop due to high inventories exceeding consumption, despite a slightly improved PMI and strong export growth Increased manufacturing activity didn't boost Cyclopentanone demand, which remained stable but weak The lackluster performance of key application sectors (pharmaceuticals, flavors, agrochemicals) further dampened demand.
November presented a mixed picture for the broader Chinese chemical industry. While consumer confidence improved and automotive sales surged, the PPI decline indicated cost reductions. Cyclopentanone production remained steady, with increased efficiency and lower raw material costs exacerbating the price decrease. Exports remained stable due to consistent global demand, especially in pharmaceuticals and perfumery. Domestic demand softened slightly due to pharmaceutical inventory optimization, but international buyers capitalized on lower prices, stocking up for Q1 2025. The fragrance industry's seasonal peak partially offset the domestic slowdown.
Overall, Q4 2024 was characterized by oversupply, leading to sustained price pressure. Positive macroeconomic indicators like export growth and improved manufacturing activity had limited impact on Cyclopentanone demand. Weak growth in key sectors and cautious procurement strategies created challenges for market participants, who struggled with high inventories and profit margins. The price decline continued throughout the quarter, creating a difficult environment for businesses operating in this market segment.
Europe
In Q4 2024, the Cyclopentanone market in the European region, particularly Germany showed price stability. October's stable prices, despite a prolonged Eurozone manufacturing downturn, were potentially supported by a healthy agricultural sector (indicated by strong phosphate fertilizer production). However, rising ammonia costs due to import delays and port congestion impacted production costs. November maintained price stability, but moderate production due to limited ammonia, unfavorable weather impacting agricultural demand, and a worsening manufacturing downturn negatively affected the Cyclopentanone market. Rail congestion further hampered supply.
December saw a slight price decrease, reflecting sluggish demand due to the holiday season and adverse weather. The sharp decline in Eurozone manufacturing output and port disruptions further reduced demand for Cyclopentanone. Reduced feedstock ammonia cost support added to production cost pressures.
Overall, Q4 2024 saw Cyclopentanone price stability in Germany, despite a challenging economic climate. The prolonged manufacturing downturn significantly reduced industrial demand. While the agricultural sector offered some support, unfavorable weather, rising energy costs, and supply chain disruptions created significant challenges for market participants.
